α-Glucosidase Inhibitors from Salvia circinata. Flores-Bocanegra, L., González-Andrade, M., Bye, R., Linares, E., & Mata, R. Journal of Natural Products, 2017.
abstract   bibtex   
© 2017 The American Chemical Society and American Society of Pharmacognosy. A dried infusion prepared from the aerial parts of Salvia circinata did not provoke acute toxicity in mice (LD 50 > 5 g/kg). This infusion showed poor hypoglycemic and antihyperglycemic effects (100-570 mg/kg) when tested in normal and hyperglycemic mice using acute and oral glucose tolerance tests, respectively. However, this infusion possessed antihyperglycemic action in vivo during an oral sucrose tolerance test (31.6-316 mg/kg), suggesting the presence of α-glucosidase inhibitors in S. circinata. Fractionation of a nonpolar extract of the aerial parts of the plant yielded a new biflavone (1) and four new neoclerodane diterpenoid glucosides (2-5) along with the known compounds amarisolide (6), pedalitin (7), apigenin-7-O-β-d-glucoside (8), and the flavone 2-(3,4-dimethoxyphenyl)-5,6-dihydroxy-7-methoxy-4H-chromen-4-one (9). Compounds 1 and 6-9 were active against mammalian α-glucosidases; 6 and 7 were also active against a recombinant α-glucosidase from Ruminococcus obeum and reduced significantly the postprandial peak during an oral sucrose tolerance test in healthy mice, consistent with their α-glucosidase inhibitory activity. Molecular docking and dynamic studies revealed that compounds 6 and 7 might bind to α-glucosidases at the catalytic center of the enzyme.
@article{
 title = {α-Glucosidase Inhibitors from Salvia circinata},
 type = {article},
 year = {2017},
 identifiers = {[object Object]},
 volume = {80},
 id = {ee657f2b-a296-3fcc-9006-3471b506ba20},
 created = {2017-08-31T00:54:40.612Z},
 file_attached = {false},
 profile_id = {7da96f2b-cf05-3448-83f2-2c1e91a65514},
 last_modified = {2017-08-31T00:57:48.711Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {false},
 hidden = {false},
 private_publication = {false},
 abstract = {© 2017 The American Chemical Society and American Society of Pharmacognosy. A dried infusion prepared from the aerial parts of Salvia circinata did not provoke acute toxicity in mice (LD 50   >  5 g/kg). This infusion showed poor hypoglycemic and antihyperglycemic effects (100-570 mg/kg) when tested in normal and hyperglycemic mice using acute and oral glucose tolerance tests, respectively. However, this infusion possessed antihyperglycemic action in vivo during an oral sucrose tolerance test (31.6-316 mg/kg), suggesting the presence of α-glucosidase inhibitors in S. circinata. Fractionation of a nonpolar extract of the aerial parts of the plant yielded a new biflavone (1) and four new neoclerodane diterpenoid glucosides (2-5) along with the known compounds amarisolide (6), pedalitin (7), apigenin-7-O-β-d-glucoside (8), and the flavone 2-(3,4-dimethoxyphenyl)-5,6-dihydroxy-7-methoxy-4H-chromen-4-one (9). Compounds 1 and 6-9 were active against mammalian α-glucosidases; 6 and 7 were also active against a recombinant α-glucosidase from Ruminococcus obeum and reduced significantly the postprandial peak during an oral sucrose tolerance test in healthy mice, consistent with their α-glucosidase inhibitory activity. Molecular docking and dynamic studies revealed that compounds 6 and 7 might bind to α-glucosidases at the catalytic center of the enzyme.},
 bibtype = {article},
 author = {Flores-Bocanegra, L. and González-Andrade, M. and Bye, R. and Linares, E. and Mata, R.},
 journal = {Journal of Natural Products},
 number = {5}
}

Downloads: 0